7.9MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US68217N1054
CUSIP
68217N105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.21
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.32
Wall Street Target Price
11.50
EPS Estimate Current Year
-1.23
EPS Estimate Next Year
-1.11
EPS Estimate Current Quarter
-0.2717
EPS Estimate Next Quarter
-0.2333
Most Recent Quarter
-
Revenue TTM
8,095,000
Gross Profit TTM
-34,498,000
EBITDA
-72,408,000
Profit Margin
0.00%
Return On Assets TTM
-25.02%
Return On Equity TTM
-166.90%
Revenue Per Share TTM
0.147
Qtly Revenue Growth YOY
214.30%
Diluted Eps TTM
-1.32
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.9753
Price Book MRQ
0.2326
Enterprise Value Revenue
12
Enterprise Value EBITDA
-2
274.00
1.46%620.00
0.80%697.42
0.00%148.91
-5.88%88.76
-3.85%433.70
-3.74%232.76
-3.39%78.40
-3.14%91.94
-2.91%543.70
-2.67%